Advertisement
*
Reproduction permitted for personal use only. For reprints and reprint permission, contact reprints@wistechnology.com.

Prodesse begins clinical trials for flu virus detection

Waukesha, Wis. - Several major healthcare institutions have begun clinical trials on a flu detection product developed by Prodesse, Inc., a Waukesha-based biotechnology company.

The product, known as ProFlu+, is being billed as a more complete and user-friendly test to help laboratories detect and differentiate several flu viruses, including Influenza A and B and the Respiratory Syncytial Virus.

Prodesse has been working with the Food and Drug Administration to design the clinical studies, and it expects to submit an application for FDA clearance following the completion of the trials this spring.

The company said ProFlu, which is designed for use with existing automated platforms, addresses several shortcomings with existing methods of respiratory virus detection. They include the lack of a clinically useful turnaround time and the need for subjective interpretation.

Related stories
Advertisement
Prodesse joins forces with Invitrogen

Prodesse enters patent agreement with Roche

Teresa Esser: Entrepreneurial Profile: Kelly Henrickson, founder of Prodesse, Inc.

-Add Your Comment

Name:
E-mail:

Comment Policy: WTN News accepts comments that are on-topic and do not contain advertisements, profanity or personal attacks. Comments represent the views of the individuals who post them and do not necessarily represent the views of WTN Media or our partners, advertisers, or sources. Comments are moderated and are not immediately posted. Your email address will not be posted.

WTN Media cannot accept liability for the content of comments posted here or verify their accuracy. If you believe this comment section is being abused, contact edit@wistechnology.com.

WTN Media Presents